GO:0051728 cell cycle switching, mitotic to meiotic cell cycle: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051728 describes the biological process by which a cell switches its division mode from mitosis to meiosis.
• The switch is controlled by nutrient and developmental signals that converge on conserved kinase cascades and RNA-binding proteins.
• In fission yeast, phosphorylation of the RNA-binding protein Mei2 by Pat1 kinase controls the mitotic-to-meiotic switch.
• In Drosophila females, the mitosis-to-meiosis transition is transcriptionally programmed and coordinated with germline stem cell proliferation and polarity.
• Dysregulation of meiotic entry is linked to testicular germ cell tumors and other reproductive disorders.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of switch regulators in yeast, fly, worm, and mammalian cells.
Description
The transition from mitotic proliferation to meiotic differentiation is a fundamental cell-fate decision that ensures the production of haploid gametes. GO:0051728, cell cycle switching, mitotic to meiotic cell cycle, captures the process by which a cell exits the mitotic cycle and enters the meiotic program. This switch is not a passive consequence of cell cycle arrest but an actively regulated transition that integrates nutritional status, developmental cues, and cell-cycle machinery. In the fission yeast Schizosaccharomyces pombe, the switch is controlled by the Pat1 kinase and the RNA-binding protein Mei2, which together form a molecular toggle between mitosis and meiosis. In metazoans, the transition is embedded in germline development and is coordinated with stem cell proliferation, polarity, and cell-fate specification. In Drosophila females, the mitosis-to-meiosis transition involves a coordinated transcriptional program that activates meiotic genes while repressing mitotic regulators. In C. elegans, the maternal-to-zygotic transition and germline development provide another context in which meiotic entry is tightly regulated. Understanding this process is important for reproductive biology, cancer research, and the development of cell-based models of gametogenesis.
cell cycle switching, mitotic to meiotic cell cycle At A Glance
| GO ID | GO:0051728 |
|---|---|
| GO term | cell cycle switching, mitotic to meiotic cell cycle |
| Ontology | biological_process |
| Synonym | cell cycle switching, mitosis to meiosis; conversion to meiosis; entry into meiosis; initiation of meiosis; meiotic entry |
| Major function | Regulates the transition from mitotic proliferation to meiotic differentiation |
| Key regulators | Pat1 kinase, Mei2 RNA-binding protein, Mos-MAPK pathway, developmental transcription factors |
| Model organisms | Schizosaccharomyces pombe, Saccharomyces cerevisiae, Drosophila melanogaster, Caenorhabditis elegans |
| Disease relevance | Testicular germ cell tumors, reproductive disorders |
What Is GO:0051728?
GO:0051728 is defined as the process in which a cell switches cell cycle mode from mitotic to meiotic division. It encompasses the regulatory events that terminate mitotic cycling and initiate the meiotic program, including the activation of meiosis-specific genes and the suppression of mitotic cell cycle drivers.
Why Is cell cycle switching, mitotic to meiotic cell cycle Important in Cell Biology?
The mitotic-to-meiotic switch is essential for sexual reproduction and genome stability. Defects in this process can lead to infertility, germ cell tumors, and developmental abnormalities. Because the switch is conserved from yeast to humans, model organisms provide powerful systems to dissect its molecular logic and to identify therapeutic targets.
• Ensures the production of haploid gametes for sexual reproduction.
• Prevents inappropriate meiotic entry in mitotically dividing cells.
• Coordinates nutritional and developmental signals with cell cycle progression.
• Dysregulation is associated with testicular germ cell tumors.
• Provides a paradigm for studying cell-fate switches and irreversible differentiation.
• Informs reproductive medicine and fertility preservation.
• Offers targets for contraceptives and germ cell cancer therapies.
• Enables synthetic biology approaches to control cell cycle mode.
What Happens During cell cycle switching, mitotic to meiotic cell cycle?
Signal Integration and Commitment
In simple terms: The cell checks whether conditions are right before committing to meiosis.
In budding yeast, the switch from mitosis to meiosis requires integration of nutrient signals, mating-type information, and cell cycle status. The decision to enter meiosis is made during the G1 phase and involves the activation of the master transcriptional regulator Ime1, which is controlled by multiple signaling pathways. In fission yeast, nitrogen starvation triggers the switch by inactivating the Pat1 kinase, which otherwise phosphorylates and inhibits the RNA-binding protein Mei2. This signal integration ensures that meiosis is initiated only under favorable conditions.
Inactivation of Mitotic Cyclin-Dependent Kinases
In simple terms: The engine that drives mitosis is turned off.
The mitotic-to-meiotic switch requires the downregulation of cyclin-dependent kinase (CDK) activity. In fission yeast, Pat1 kinase is a key regulator that maintains mitotic cycling by phosphorylating Mei2; upon nitrogen starvation, Pat1 is inactivated, allowing Mei2 to accumulate and promote meiosis. In budding yeast, the switch involves the inactivation of CDK by the cyclin-dependent kinase inhibitor Sic1 and the degradation of mitotic cyclins. This step is critical for exiting the mitotic cycle and establishing the meiotic program.
Activation of Meiosis-Specific Gene Expression
In simple terms: The cell turns on the genes needed for meiosis.
Once the mitotic program is suppressed, meiosis-specific genes are transcriptionally activated. In fission yeast, Mei2 binds to specific RNAs and promotes their translation, including the mRNA encoding the meiotic inducer Ste11. In Drosophila females, the mitosis-to-meiosis transition involves a coordinated transcriptional program that activates meiotic genes such as those encoding synaptonemal complex proteins and recombination factors. In C. elegans, the maternal-to-zygotic transition and germline development involve the regulated expression of meiotic genes.
Chromosome Reorganization and Pre-Meiotic S Phase
In simple terms: The cell prepares its chromosomes for meiosis.
After the switch, cells undergo a pre-meiotic S phase followed by meiotic prophase, during which homologous chromosomes pair, synapse, and recombine. In Drosophila females, the transition from mitosis to meiosis is accompanied by changes in chromosome architecture and the assembly of the synaptonemal complex. In fission yeast, Mei2 promotes the pre-meiotic S phase and the subsequent meiotic divisions.
Asymmetric Division and Oocyte Specification
In simple terms: In females, the switch is linked to the production of asymmetric daughter cells.
In Drosophila and other metazoans, the mitosis-to-meiosis transition is coupled to asymmetric divisions that specify the oocyte. The Mos-MAPK pathway is a key regulator of meiotic cell cycle progression and asymmetric oocyte divisions. Phosphoproteomic studies have identified Mos-MAPK targets that control these processes. In C. elegans, the maternal-to-zygotic transition and germline development also involve asymmetric divisions and meiotic entry.
Key Genes Involved in GO:0051728 cell cycle switching, mitotic to meiotic cell cycle
The following genes and proteins are central to the regulation and execution of the mitotic-to-meiotic switch across model organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Pat1 | Kinase that phosphorylates Mei2 to inhibit meiosis in fission yeast | Key regulator of the switch; target for genetic studies |
| Mei2 | RNA-binding protein that promotes meiosis when dephosphorylated | Central effector of the switch; RNA targets studied |
| Ste11 | Transcription factor that activates meiosis-specific genes in fission yeast | Downstream target of Mei2; regulates meiotic entry |
| Ime1 | Master transcriptional regulator of meiosis in budding yeast | Integrates nutrient and cell cycle signals |
| Sic1 | CDK inhibitor that promotes exit from mitosis in budding yeast | Required for meiotic entry |
| Mos | Kinase that activates MAPK during meiotic maturation | Regulates asymmetric oocyte divisions |
| MAPK | Downstream effector of Mos in oocyte maturation | Phosphorylates targets controlling meiotic divisions |
| Bam | Germline differentiation factor in Drosophila | Coordinates proliferation and meiotic entry |
| Bgcn | Partner of Bam in Drosophila germline | Regulates the mitosis-to-meiosis transition |
| Sxl | RNA-binding protein that controls sex-specific splicing in Drosophila | Affects meiotic entry in females |
| Otu | Deubiquitinase in Drosophila germline | Regulates the switch and germline development |
| Nanog | Pluripotency factor in mammals | May influence germ cell fate and meiotic entry |
| Oct4 | Pluripotency factor in mammals | Expressed in germ cell tumors; linked to meiotic dysregulation |
| Vasa | DEAD-box helicase in germline | Marker of germ cells; involved in meiotic progression |
| Pie-1 | Zinc finger protein in C. elegans germline | Regulates maternal-to-zygotic transition and meiotic entry |
| Gld-1 | RNA-binding protein in C. elegans | Controls meiotic entry and germline development |
| Fbf-1 | Pumilio-family RNA-binding protein in C. elegans | Regulates the mitosis-to-meiosis switch |
How Is cell cycle switching, mitotic to meiotic cell cycle Regulated?
The mitotic-to-meiotic switch is regulated by nutrient-sensing pathways, developmental signals, and cell cycle checkpoints. In budding yeast, the switch is controlled by the integration of nutrient signals through the cAMP-PKA pathway and the mating-type information. In fission yeast, nitrogen starvation inactivates Pat1 kinase, which relieves inhibition of Mei2 and allows meiotic entry. In Drosophila, the switch is regulated by germline-intrinsic factors such as Bam and Bgcn, which coordinate proliferation and differentiation. In C. elegans, RNA-binding proteins such as Gld-1 and Fbf-1 control the timing of meiotic entry. These regulatory mechanisms ensure that meiosis occurs only under appropriate conditions and in the correct cell types.
cell cycle switching, mitotic to meiotic cell cycle and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Pat1 | Infertility (fission yeast model) | Knockout in S. pombe |
| Mei2 | Meiotic failure (fission yeast model) | Point mutation or knockout in S. pombe |
| Bam | Germline tumor / infertility (Drosophila) | Knockout or overexpression in Drosophila |
| Mos | Oocyte maturation defects (vertebrate models) | Knockout in mouse or Xenopus |
| Oct4 | Testicular germ cell tumors | Knockdown or overexpression in human cell lines |
Testicular Germ Cell Tumors
Dysregulation of the mitotic-to-meiotic switch is associated with testicular germ cell tumors. Expression patterns of mitotic and meiotic cell cycle regulators are altered in testicular cancer compared to normal development. The switch from mitotic proliferation to meiotic differentiation is a key event in germ cell development, and its failure can lead to tumorigenesis.
Infertility and Reproductive Disorders
Defects in meiotic entry can cause infertility due to failure to produce haploid gametes. In model organisms, mutations in genes controlling the switch, such as Mei2 in fission yeast or Bam in Drosophila, result in sterility. In humans, similar mechanisms may underlie certain cases of infertility.
Developmental Disorders
The mitosis-to-meiosis transition is tightly coupled to germline development. Disruption of this process can lead to developmental abnormalities in the germline, as seen in C. elegans and Drosophila mutants. Understanding these mechanisms may provide insights into human germ cell development and related disorders.
From cell cycle switching, mitotic to meiotic cell cycle-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is Pat1 required for the mitotic-to-meiotic switch? | Pat1 knockout in S. pombe |
| Does phosphorylation of Mei2 control meiotic entry? | Mei2 point mutation (phospho-null) in S. pombe |
| What are the RNA targets of Mei2? | Mei2 tagged knock-in for RIP-seq in S. pombe |
| How does Bam regulate the switch in Drosophila? | Bam knockout or overexpression in Drosophila germline |
| What is the role of Mos-MAPK in oocyte maturation? | Mos knockout or point mutation in mouse oocytes |
| How does Gld-1 control meiotic entry in C. elegans? | Gld-1 knockout or tagged knock-in in C. elegans |
How to Study the cell cycle switching, mitotic to meiotic cell cycle Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome changes | Identify meiotic genes activated during the switch |
| Phosphoproteomics | Phosphorylation events | Map Mos-MAPK targets in oocytes |
| CRISPR knockout screen | Gene requirement | Identify regulators of meiotic entry |
| RIP-seq | RNA targets of RNA-binding proteins | Identify Mei2 targets in fission yeast |
| Live-cell imaging | Chromosome dynamics and cell cycle progression | Visualize the switch in germline cells |
| ChIP-seq | Transcription factor binding | Map Ime1 binding sites in budding yeast |
| Proteomics | Protein abundance and interactions | Study Mei2 complex composition |
Transcriptomics and RNA-seq
RNA-seq can be used to profile gene expression changes during the mitosis-to-meiosis transition. In Drosophila females, transcriptomic analysis has identified meiotic genes that are activated during the switch. In C. elegans, RNA-seq has been used to study the maternal-to-zygotic transition.
Phosphoproteomics
Phosphoproteomics identifies kinase substrates and signaling events. In oocytes, phosphoproteomic identification of Mos-MAPK targets has revealed key regulators of meiotic cell cycle and asymmetric divisions. This approach can be applied to other systems to map the phosphorylation events that control the switch.
Genetic Screens and CRISPR Libraries
CRISPR-based screens can identify genes required for meiotic entry. In yeast, genome-wide knockout libraries have been used to identify regulators of the switch. In metazoans, CRISPR screens in germline stem cells can uncover conserved factors.
Imaging and Live-Cell Analysis
Fluorescence imaging of chromosome dynamics and meiotic markers can visualize the switch in real time. In C. elegans, imaging of germline development has revealed the timing of meiotic entry. In Drosophila, live imaging of germline stem cells has shown the transition from mitosis to meiosis.
How CRISPR Can Be Used to Study GO:0051728 cell cycle switching, mitotic to meiotic cell cycle
Knockout
CRISPR knockout of candidate genes can test their requirement for the mitotic-to-meiotic switch. For example, knocking out Pat1 in fission yeast leads to inappropriate meiotic entry. In Drosophila, knockout of Bam causes germline tumors and blocks differentiation. EDITGENE provides custom knockout cell models in yeast, fly, worm, and mammalian cells.
Point Mutation
Point mutations can dissect phosphorylation sites and functional domains. A phospho-null mutation in Mei2 can test whether phosphorylation by Pat1 controls meiotic entry. EDITGENE offers precise point mutation services using CRISPR base editing or HDR.
Knock-in
Knock-in of tags or reporters allows visualization and biochemical analysis of switch regulators. A GFP knock-in of Mei2 can be used to monitor its localization and dynamics. EDITGENE provides tagged knock-in models for live-cell imaging and proteomics.
Overexpression
Overexpression of switch regulators can force meiotic entry or block it. Overexpression of Mei2 in fission yeast induces meiosis even under non-inducing conditions. EDITGENE offers overexpression cell models using safe-harbor integration or inducible systems.
How EDITGENE Supports cell cycle switching, mitotic to meiotic cell cycle Research
Researchers studying cell cycle switching, mitotic to meiotic cell cycle-related genes often need to determine whether a candidate gene is causally involved in the transition or merely correlated with it. CRISPR-based models provide the gold standard for establishing causality, and EDITGENE offers a comprehensive suite of services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for cell cycle switching, mitotic to meiotic cell cycle research.
Frequently Asked Questions About cell cycle switching, mitotic to meiotic cell cycle
What is GO:0051728?
GO:0051728 is the Gene Ontology term for cell cycle switching, mitotic to meiotic cell cycle, the process by which a cell switches from mitotic division to meiotic division.
What genes are involved in the mitotic to meiotic switch?
Key genes include Pat1, Mei2, and Ste11 in fission yeast; Ime1 and Sic1 in budding yeast; Bam and Bgcn in Drosophila; and Mos and MAPK in oocytes.
How is the switch from mitosis to meiosis regulated?
The switch is regulated by nutrient signals, developmental cues, and kinase cascades that inactivate mitotic CDKs and activate meiosis-specific transcription factors.
What happens if the mitotic to meiotic switch fails?
Failure of the switch can lead to infertility, germ cell tumors, and developmental abnormalities.
Which model organisms are used to study meiotic entry?
Common models include Schizosaccharomyces pombe, Saccharomyces cerevisiae, Drosophila melanogaster, and Caenorhabditis elegans.
What is the role of Mei2 in meiosis?
Mei2 is an RNA-binding protein that promotes meiosis when dephosphorylated by Pat1 kinase in fission yeast.
How does Pat1 kinase control the switch?
Pat1 phosphorylates Mei2 to inhibit meiosis; nitrogen starvation inactivates Pat1, allowing Mei2 to function.
What is the Mos-MAPK pathway?
Mos is a kinase that activates MAPK during oocyte maturation and controls asymmetric divisions.
Can CRISPR be used to study the mitotic to meiotic switch?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test the function of switch regulators.
What diseases are linked to meiotic entry defects?
Testicular germ cell tumors and infertility are linked to defects in the mitotic-to-meiotic switch.
Conclusion
GO:0051728, cell cycle switching, mitotic to meiotic cell cycle, is a conserved and tightly regulated process that is essential for sexual reproduction. Research in yeast, Drosophila, and C. elegans has revealed core mechanisms involving kinase cascades, RNA-binding proteins, and transcriptional programs. Dysregulation of this switch is associated with germ cell tumors and infertility. CRISPR-based models offer powerful tools to dissect these mechanisms and to identify new therapeutic targets. EDITGENE provides comprehensive services to support this research.
References
- 1. Avilov I et al.. 2025. Phosphoproteomic identification of Mos-MAPK targets in meiotic cell cycle and asymmetric oocyte divisions.. J Cell Biol 224(12) PMID: 41123450
- 2. Watanabe Y et al.. 1997. Phosphorylation of RNA-binding protein controls cell cycle switch from mitotic to meiotic in fission yeast.. Nature 386(6621):187-90 PMID: 9062192
- 3. Honigberg SM et al.. 2003. Signal pathway integration in the switch from the mitotic cell cycle to meiosis in yeast.. J Cell Sci 116(Pt 11):2137-47 PMID: 12730290
- 4. Watanabe Y et al.. 1997. [Cell cycle switch from mitotic to meiotic in fission yeast: critical role for an RNA-binding protein].. Tanpakushitsu Kakusan Koso 42(16):2581-9 PMID: 9404154
- 5. Robertson S et al.. 2015. The Maternal-to-Zygotic Transition in C. elegans.. Curr Top Dev Biol 113:1-42 PMID: 26358869
- 6. Vallés AM et al.. 2024. Transcriptomic analysis of meiotic genes during the mitosis-to-meiosis transition in Drosophila females.. Genetics 228(2) PMID: 39225982
- 7. Hinnant TD et al.. 2020. Coordinating Proliferation, Polarity, and Cell Fate in the Drosophila Female Germline.. Front Cell Dev Biol 8:19 PMID: 32117961
- 8. Diederichs S et al.. 2005. Expression patterns of mitotic and meiotic cell cycle regulators in testicular cancer and development.. Int J Cancer 116(2):207-17 PMID: 15800920
